Biogen Inc (NASDAQ:BIIB)
| 333.00 Delayed Data As of Feb 14 |  -1.25 / -0.37%Today’s Change | 215.78 Today|||52-Week Range 374.99 | +12.22% Year-to-Date |
Latest BIIB News | Press Releases
| Better Buy: Biogen vs. Bristol-Myers Squibb Feb 16 / MotleyFool.com - Paid Partner Content | 3 Biotech Companies Analyzed Feb 07 / MotleyFool.com - Paid Partner Content |
| Warren Buffett's Berkshire Hathaway Dives Into Biotechnology Feb 15 / MotleyFool.com - Paid Partner Content | Roche Presents Spinal Muscular Atrophy Drug Data Feb 07 / MotleyFool.com - Paid Partner Content |
| 3 Biotech Stocks That Made Early Shareholders Millionaires Feb 13 / MotleyFool.com - Paid Partner Content | Is This Under-the-Radar Stock Set to Succeed in Alzheimer's Disease? Feb 07 / MotleyFool.com - Paid Partner Content |
| Will Biogen’s Big Patent Victory Ease Investor Worries About Its Alzheimer’s Drug? Feb 11 / MotleyFool.com - Paid Partner Content | Why Amgen Stock Dropped 10.4% in January Feb 05 / MotleyFool.com - Paid Partner Content |
| A Double Failure of Alzheimer's Drugs Feb 10 / MotleyFool.com - Paid Partner Content | Biogen Surges After Winning Crucial Multiple Sclerosis Drug Patent Feb 05 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 334.25 |
| Today’s open | 334.00 |
| Day’s range | 331.83 - 335.40 |
| Volume | 1,023,247 |
| Average volume (3 months) | 2,126,548 |
| Market cap | $58.3B |
Data as of 4:00pm ET, 02/14/2020
Growth & Valuation
| Earnings growth (last year) | +45.55% |
| Earnings growth (this year) | -2.90% |
| Earnings growth (next 5 years) | +2.09% |
| Revenue growth (last year) | +5.49% |
| P/E ratio | 10.6 |
| Price/Sales | 4.37 |
| Price/Book | 4.37 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ILMNIllumina Inc | +7.54 | +2.59% |
| GILDGilead Sciences | +0.76 | +1.14% |
| BMRNBiomarin Pharmaceuti... | +0.77 | +0.87% |
| EXASExact Sciences Corp | +3.42 | +3.61% |
Data as of 4:00pm ET, 02/14/2020
Financials
| Next reporting date | April 22, 2020 |
| EPS forecast (this quarter) | $7.84 |
| Annual revenue (last year) | $12.7B |
| Annual profit (last year) | $5.9B |
| Net profit margin | 46.32% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
